AQR Capital Management
NNVC icon

AQR Capital Management’s NanoViricides NNVC Stock Holding History

AQR Capital Management’s Portfolio NNVC Stock Details NNVC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-1,370
Closed -$62K – 2241
2015
Q1 		$62K Sell
1,370
-1,065
-44% -$56.8K ﹤0.01% 2114
2014
Q4 		$132K Sell
2,435
-1,670
-41% -$111K ﹤0.01% 2415
2014
Q3 		$246K Hold
4,105
– – ﹤0.01% 2254
2014
Q2 		$347K Hold
4,105
– – ﹤0.01% 2146
2014
Q1 		$263K Buy
+4,105
New +$351K ﹤0.01% 2318

Other funds holding NNVC

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
CG
Colony Group Boston, Massachusetts $6.66B AUM 18.65% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

AQR Capital Management's NNVC Position: Q2 2015 in Review

AQR Capital Management sold out of NanoViricides (NNVC) in Q2 2015, closing a stake of 1,370 shares — an estimated $62K sold.

AQR Capital Management first reported a position in NNVC in Q1 2014 and held it in 5 quarters. The position peaked at $347K in Q2 2014. 48 funds tracked by Wall St. Rank hold NNVC as of Q2 2015.

  • AQR Capital Management reported no remaining NanoViricides position as of Q2 2015 after selling out during the quarter.
  • AQR Capital Management sold 1,370 NanoViricides shares in Q2 2015, an estimated $62K.
  • AQR Capital Management first reported a position in NanoViricides in Q1 2014 and held it in 5 quarters.
  • AQR Capital Management's NanoViricides position peaked at $347K in Q2 2014.
  • 48 funds tracked by Wall St. Rank held NanoViricides as of Q2 2015.

Based on AQR Capital Management's 13F filing for Q2 2015, filed 14 Aug 2015.